Paragon 28, Inc. (FNA), a company focused on the foot and ankle orthopedic medical devices, said on Thursday that its Chief Financial Officer, Stephen Deitsch, will step down effective April 5, to pursue an opportunity with OrganOx Limited.
Shares of HubSpot (HUBS) are gaining over 9 percent on Thursday, following a report from Reuters stating that Alphabet, Inc.'s (GOOG) Google is mulling over an acquisition offer for the digital marketing company.
eFFECTOR Therapeutics, Inc. (EFTR) announced Thursday topline results from the primary analysis of the randomized Phase 2 KICKSTART trial which tested tomivosertib or placebo, each combined with pembrolizumab, as frontline treatment for patients with non-small cell lung cancer (NSCLC) with PD-L1 =50%.
Shares of HubSpot (HUBS) are gaining over 9 percent on Thursday, following a report from Reuters stating that Alphabet, Inc.'s (GOOG) Google is mulling over an acquisition offer for the digital marketing company.
MIL-OSI USA: FDA Approves New Antibiotic for Three Different Uses foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.